[Liver organoid technology and its related progress in liver disease research]. [PDF]
Wang ZR +4 more
europepmc +1 more source
[Analysis and comparison of bile acid metabolism characteristics in children and adults with metabolic- associated fatty liver disease]. [PDF]
Yang CH +7 more
europepmc +1 more source
[<i>Ching Shum</i> Pills alleviates non-alcoholic fatty liver disease in mice by ameliorating lipid metabolism disorders]. [PDF]
Luo B +7 more
europepmc +1 more source
[Introduction to the update points of the 2025 European Association for the Study of Liver clinical practice guidelines for the management of chronic hepatitis B infection]. [PDF]
Zhuang H.
europepmc +1 more source
[Research progress in the role of caspase-3 in regulating pyroptosis and apoptosis in non-alcoholic fatty liver disease]. [PDF]
Cao S, Long Y, Yang L.
europepmc +1 more source
[Altered oral microbiome and metabolites are associated with improved lipid metabolism in HBV-infected patients with metabolic dysfunction-associated fatty liver disease]. [PDF]
Zhang J +9 more
europepmc +1 more source

